Table 1.
Age | No. |
Diagnostic grouping |
Sex |
GMFCS* |
MACS/mini-MACS* |
CFCS |
LSS |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
mos | (%) | CP | O | NM | D | M | F | I/II | III | IV/V | I/II | III | IV/V | I/II | III | IV/V | 6–8 | 5 | 2–4 |
6–12 | 3 (4) | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 3 | 3 | ||||||
13–18 | 15 (20) | 8 | 6 | 1 | 7 | 8 | 2 | 2 | 11 | 4 | 3 | 8 | 15 | 3 | 12 | ||||
19–24 | 8 (10) | 4 | 1 | 3 | 3 | 5 | 2 | 6 | 3 | 2 | 3 | 1 | 7 | 4 | 4 | ||||
25–30 | 7 (9) | 6 | 1 | 4 | 4 | 2 | 6 | 3 | 2 | 2 | 2 | 5 | 2 | 5 | |||||
31–36 | 9 (12) | 8 | 1 | 5 | 4 | 1 | 3 | 5 | 4 | 3 | 2 | 4 | 5 | 2 | 2 | 5 | |||
37–42 | 16 (21) | 14 | 1 | 1 | 7 | 9 | 1 | 6 | 9 | 3 | 6 | 7 | 2 | 2 | 12 | 2 | 5 | 9 | |
43–48 | 7 (9) | 7 | 4 | 3 | 4 | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 1 | 4 | ||||
49–54 | 6 (8) | 5 | 1 | 4 | 2 | 1 | 5 | 1 | 5 | 6 | 2 | 4 | |||||||
55–60 | 3 (4) | 1 | 1 | 1 | 3 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | |||||
61–68 | 1 (1) | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||||
Totals | 75 | 55 | 12 | 4 | 4 | 39 | 36 | 5 | 22 | 48 | 22 | 20 | 33 | 5 | 11 | 59 | 9 | 18 | 48 |
% | 100 | 73.33 | 16 | 5.33 | 5.33 | 52 | 48 | 6.7 | 29.3 | 64 | 29.3 | 26.7 | 44 | 6.7 | 14.7 | 78.6 | 12 | 24 | 64 |
*: or equivalent functional ability (when used with a diagnosis other than CP); CFCS: Communication Function Classification System; GMFCS: Gross Motor Function Classification System; CP: cerebral palsy or a diagnosis falling under the contemporary definition of cerebral palsy30; D: neurodegenerative diagnosis; LSS: Level of Sitting Scale; mos: months; MACS: Manual Abilities Classification System; NM: neuromuscular diagnosis, e.g. spinal muscular atrophy; no.: number; O: other neurological diagnoses, e.g. spina bifida.
Source: reproduced with permission from Smithers-Sheedy et al., 2014.30